Changes — raw log (19,220 events)
Every event the pipeline observed across all networks — payouts, statuses, geos, caps, metrics — one row per event, nothing filtered. Back to movements that matter. Subscribe: Atom feed.
| When | Network | Offer | Change |
|---|---|---|---|
| 2d ago | dr.cash | Erectorro free | Approval rate 23.89% → 24.43% (+2.3%) |
| 2d ago | dr.cash | Erectonator Max free | Approval rate 20.53% → 20.85% (+1.6%) |
| 2d ago | dr.cash | Jucyman Protency Max free | Approval rate 20.78% → 21.33% (+2.6%) |
| 2d ago | dr.cash | Uroprostan | Approval rate 25% → 33.33% (+33.3%) |
| 2d ago | dr.cash | Vianelle free | Approval rate 16.24% → 17.05% (+5.0%) |
| 2d ago | dr.cash | O caps | Approval rate 22.41% → 20% (-10.8%) |
| 2d ago | dr.cash | ABSlim | Approval rate 44.44% → 41.67% (-6.2%) |
| 2d ago | dr.cash | Aktiv Kapi | Approval rate 14.29% → 8.33% (-41.7%) |
| 2d ago | dr.cash | Elastica | Approval rate 84.62% → 82.35% (-2.7%) |
| 2d ago | dr.cash | Prostalis | Approval rate 20.31% → 21.67% (+6.7%) |
| 2d ago | dr.cash | Prostalis low price | Approval rate 42.86% → 41.18% (-3.9%) |
| 2d ago | dr.cash | Cleopatra cream low price | Approval rate 16.67% → 15.38% (-7.7%) |
| 2d ago | dr.cash | Clora Balance | Approval rate 53.33% → 60% (+12.5%) |
| 2d ago | dr.cash | MANTRIX (male urination) | Approval rate 42.86% → 45.45% (+6.0%) |
| 2d ago | dr.cash | Broten | Approval rate 67.92% → 64.29% (-5.3%) |
| 2d ago | dr.cash | Hairstim free | Approval rate 17.13% → 17.88% (+4.4%) |
| 2d ago | dr.cash | Flexosamine PRO | Approval rate 10.71% → 12.5% (+16.7%) |
| 2d ago | dr.cash | JoActive | Approval rate 44.44% → 50% (+12.5%) |
| 2d ago | dr.cash | HELMIRON | Approval rate 41.67% → 45.45% (+9.1%) |
| 2d ago | dr.cash | HELMIRON | Approval rate 40.09% → 39.97% (-0.3%) |
| 2d ago | dr.cash | IdealFit low price | Approval rate 25.74% → 22.9% (-11.0%) |
| 2d ago | dr.cash | DiaformRX low price | Approval rate 50% → 46.15% (-7.7%) |
| 2d ago | dr.cash | ArtiZynt Capsules low price | Approval rate 18.18% → 20% (+10.0%) |
| 2d ago | dr.cash | Glucoven free | Approval rate 22.9% → 23.34% (+1.9%) |
| 2d ago | dr.cash | CYSTOBACT | Approval rate 40% → 37.5% (-6.3%) |
| 2d ago | dr.cash | VigorPlus | Approval rate 18.1% → 18% (-0.6%) |
| 2d ago | dr.cash | ArtiZynt gel low price | Approval rate 50% → 100% (+100.0%) |
| 2d ago | dr.cash | OSTEFRIN | Approval rate 40% → 38.89% (-2.8%) |
| 2d ago | dr.cash | Diapril low price | Approval rate 83.33% → 75% (-10.0%) |
| 2d ago | dr.cash | Urinol PRO low price | Approval rate 9.94% → 9.6% (-3.4%) |
| 2d ago | dr.cash | Prostonel low price | Approval rate 75% → 33.33% (-55.6%) |
| 2d ago | dr.cash | Tricore | Approval rate 42.86% → 30% (-30.0%) |
| 2d ago | dr.cash | Tenurol | Approval rate 60% → 66.67% (+11.1%) |
| 2d ago | dr.cash | Tenurol | Approval rate 52.38% → 50% (-4.5%) |
| 2d ago | dr.cash | Visospect Forte free | Approval rate 26.92% → 28% (+4.0%) |
| 2d ago | dr.cash | ArtiZynt Capsules low price | Approval rate 15.24% → 15.35% (+0.7%) |
| 2d ago | dr.cash | Prostacor | Approval rate 33.33% → 37.5% (+12.5%) |
| 2d ago | dr.cash | GlucoZen | Approval rate 16.67% → 20% (+20.0%) |
| 2d ago | dr.cash | NixMen | Approval rate 12.74% → 11.89% (-6.7%) |
| 2d ago | dr.cash | ArtiZynt caps low price | Approval rate 20% → 33.33% (+66.7%) |
| 2d ago | dr.cash | ArtiZynt Caps low price | Approval rate 72.5% → 73.53% (+1.4%) |
| 2d ago | dr.cash | UroNature | Approval rate 45.35% → 43.82% (-3.4%) |
| 2d ago | dr.cash | Vitality Plus Ultra | Approval rate 46.15% → 42.86% (-7.1%) |
| 2d ago | dr.cash | ARVION (sexual function) | Approval rate 50.25% → 50.24% (-0.0%) |
| 2d ago | dr.cash | Parazax Complex | Approval rate 29.41% → 27.78% (-5.5%) |
| 2d ago | dr.cash | Variquit PRO | Approval rate 60% → 66.67% (+11.1%) |
| 2d ago | dr.cash | UP Lift Max | Approval rate 25% → 22.47% (-10.1%) |
| 2d ago | dr.cash | Mor Ginseng caps | Approval rate 8.36% → 8.39% (+0.4%) |
| 2d ago | dr.cash | DIZAXEN | Approval rate 70% → 66.67% (-4.8%) |
| 2d ago | dr.cash | DIZAXEN | Approval rate 60% → 50% (-16.7%) |